Relay Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -8.3% | +103.5% | +26.1% | +9.1% | -23.3% | +3.2% | -28.7% | |
| – | -15.0% | +113.6% | +26.8% | +4.4% | -24.5% | +5.1% | -28.5% | |
| – | -90.0% | +967.0% | -37.4% | -45.8% | -5.3% | -13.5% | -32.4% | |
| – | -15.6% | +90.6% | +41.3% | +4.3% | -24.9% | +4.2% | -29.0% | |
| – | – | – | -94.0% | +5.6% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +771.8% | -8.9% | -77.3% | +77.8% | – | – | – | |
| – | – | – | – | +0.0% | +0.0% | +0.0% | – | |
| – | +6.3% | -93.6% | +202.8% | +35.2% | -38.5% | +1.7% | -42.0% | |
| – | +74.6% | +13.7% | +78.4% | +162.0% | -52.5% | +67.6% | -49.6% | |
| – | +601.7% | +21.8% | +21.2% | +131.9% | +16.1% | +15.4% | -34.3% | |
| – | +48.6% | -9.2% | +30.3% | +27.8% | -12.9% | +53.0% | -45.3% | |
| – | – | – | +17.6% | +5.8% | -20.9% | +3.4% | -27.1% | |
| – | – | – | – | – | – | – | – | |
| – | +72.3% | +2,006.6% | +5.5% | +18.0% | +9.2% | +16.6% | +20.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.